Med onc and hematologist at @chudequebec with focus on lung cancer. Tweets in English for sake of conversation, mais toujours heureux de parler français!
Québec, Canada
Joined February 2017
- Tweets429
- Following305
- Followers428
- Likes1.2K
You can always count on @tompowles1 to make a Q&A session interesting and dynamic! Lively discussions like this going on in many cancer centers since ESMO24 to determine the best way forward for periop tx of MIBC #GU25
Un hommage bien mérité pour un collègue d’exception. Un mentor depuis ma première année de médecine, avec qui j’ai la chance de travailler au quotidien maintenant! Merci pour tout ce que tu fais pour les patients au quotidien
cmq.org/fr/proteger-le-publi…
1
2
150
Merci @NormandBlais de mettre en valeur notre belle gang! On est une grande famille qui traitons le cancer du poumon au Québec et le RESOT n’existerait pas sans ton implications #clcco #lcsm
The end of DD-MVAC? For me yes! Long live periop cis-gem-durva in MIBC (until we do even better!) Great talk by @tompowles1 as usual! #ESMO24
1
3
219
Always nice to see @CDNCancerTrials trials on the big stage, even when the results are not what everyone wished for… good job to all the investigators #lcsm #ESMO2024
2
347
While many of us are still amazed by the updated PFS results from CROWN, important data included regarding outcomes after dose adjustment . Tox can be tricky, individualizing the dose is important! #ASCO24
À nouveau cette année conférence mémorable de Dre Marie-Anne Archambault Grenier! Nouvelle tradition? @AMHOQ_org
6
194
Entendu en cette journée mémorable au Mont Mégantic: “bon ben j’ai vu la plus belle chose que je vais voir de ma vie… et j’ai juste 15 ans”
Sans mot devant l’éclipse totale 🌙
4
201
Merci @StephenVLiu et @NormandBlais pour l’opportunité! We’ve come a long way in the past ~5 years but still a long way to go
Report from an important NUT midline carcinoma cohort from Germany, Half non-thoracic, median 40 y.o., 31% initially misdiagnosed and median 100 days before pts were seen in specialized centers. Long way to go still for this orphan disease #lcsm
Overview of management of NUT carcinoma in Germany @LungCaJournal. Most had BRD4-NUTM1 fusion, most common initial therapy is surgery, ifosfamide-based regimens associated with better PFS. Initial misdiagnosis an issue in 31 % of the cases.
lungcancerjournal.info/artic…
6
611
Just a small part of the @chudequebec representation at #GU24 ASCO this year. 5 heme-oncs, 6 urologists, 2 rad-oncs… Let’s do even better next year!😎@castonguayOnc @LavalleeEtienne @AMCoulombeMD
1
13
373
Advanced non-RCC systemic therapy trials in a glance, thanks to @tompowles1. Great talk... and I'm a fan of the moons of Jupiter analogy! #GU24
Wow. Interesting discussions to come after seeing these curves! Positive DFS, PD-L1 non-predictive… and no OS benefit. IMO OS matters in the curative setting. #GU24
How could this incredible #ESMO23 conference end any better than with a stellar discussion by @ZPiotrowskaMD Great job my friend! #lcsm #egfr
The fact everyone saw the data a few days ago didn’t matter. Well deserved standing ovation for EV-302, patients and researchers that paved the way. Instant SoC change in advanced urothelial cancer #ESMO23
7
313
